{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:20:28Z","timestamp":1790605228111,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jad.2022.12.021","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T02:00:47Z","timestamp":1670896847000},"page":"598-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Biomarkers of ketamine's antidepressant effect: An umbrella review"],"prefix":"10.1016","volume":"323","author":[{"given":"Shakila","family":"Meshkat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeho Greg","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Di Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Ceban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Youshay","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.12.021_bb0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/0269881114544776","article-title":"Hippocampal volume and the rapid antidepressant effect of ketamine","volume":"29","author":"Abdallah","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2022.12.021_bb0010","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","article-title":"Ketamine treatment and global brain connectivity in major depression","volume":"42","author":"Abdallah","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2022.12.021_bb0015","first-page":"104","article-title":"Efficacy and safety of ketamine in bipolar depression: a systematic review","volume":"10","author":"Alberich","year":"2017","journal-title":"Rev. Psiquiatr\u00eda Salud Mental (Engl. Ed.)"},{"issue":"127","key":"10.1016\/j.jad.2022.12.021_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neubiorev.2021.05.003","article-title":"The anterior cingulate cortex as a key locus of ketamine's antidepressant action","volume":"1","author":"Alexander","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2022","key":"10.1016\/j.jad.2022.12.021_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis.","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.jad.2022.12.021_bb0030","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.biopsych.2013.02.008","article-title":"Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study","volume":"73","author":"Carlson","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2022.12.021_bb0035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2022.12.021_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.biopsych.2011.10.025","article-title":"Depression and inflammation: An intricate relationship","volume":"711","author":"Dantzer","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2022.12.021_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cns.12104","article-title":"Ketamine and peripheral inflammation","volume":"19","author":"De Kock","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2022.12.021_bb0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11920-013-0394-z","article-title":"Ketamine, sleep, and depression: current status and new questions","volume":"15","author":"Duncan","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.jad.2022.12.021_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145712000545","article-title":"Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder","volume":"16","author":"Duncan","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2022.12.021_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2012.05.042","article-title":"Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder","volume":"145","author":"Duncan","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2022.12.021_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/JCP.0000000000001209","article-title":"Body mass index as a moderator of treatment response to ketamine for major depressive disorder","volume":"40","author":"Freeman","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.021_bb0070","first-page":"117","article-title":"Neurotrophins and synaptic plasticity","author":"G\u00f3mez-Palacio-Schjetnan","year":"2013","journal-title":"NeurogenesisNeuralplast."},{"key":"10.1016\/j.jad.2022.12.021_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/sleep\/30.2.129","article-title":"Exploratory behavior, cortical BDNF expression, and sleep homeostasis","volume":"30","author":"Huber","year":"2007","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.jad.2022.12.021_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66784-2","article-title":"Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder","volume":"10","author":"Husain","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jad.2022.12.021_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/HRP.0000000000000179","article-title":"Ketamine-associated brain changes: a review of the neuroimaging literature","volume":"26","author":"Ionescu","year":"2018","journal-title":"Harvard Rev. Psychiatry."},{"issue":"89","key":"10.1016\/j.jad.2022.12.021_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.apha.2020.05.003","article-title":"Neurobiological biomarkers of response to ketamine","volume":"1","author":"Kadriu","year":"2020","journal-title":"Adv. Pharmacol."},{"issue":"8","key":"10.1016\/j.jad.2022.12.021_bb0095","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/02698811211026426","article-title":"Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review","volume":"35","author":"Kopra","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.021_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/23982128211055426","article-title":"Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: a systematic review","volume":"5","author":"Kotoula","year":"2021","journal-title":"Brain Neurosci. Adv."},{"issue":"306","key":"10.1016\/j.jad.2022.12.021_bb0105","article-title":"Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects","volume":"1","author":"Le","year":"2021","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jad.2022.12.021_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/da.22042","article-title":"Endophenotype, intermediate phenotype, biomarker: definitions, concept comparisons, clarifications","volume":"30","author":"Lenzenweger","year":"2013","journal-title":"Depression and anxiety"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2022.12.021_bb0115","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"L\u00e9pine","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"79","key":"10.1016\/j.jad.2022.12.021_bb0120","article-title":"Identifying neuroimaging biomarkers of major depressive disorder from cortical hemodynamic responses using machine learning approaches","volume":"1","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jad.2022.12.021_bb0125","first-page":"47","article-title":"The anti-inflammatory effects of ketamine: state of the art","volume":"62","author":"Loix","year":"2011","journal-title":"Acta Anaesthesiol. Belg."},{"issue":"1","key":"10.1016\/j.jad.2022.12.021_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2022.12.021_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"276","key":"10.1016\/j.jad.2022.12.021_bb0140","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis","volume":"1","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"274","key":"10.1016\/j.jad.2022.12.021_bb0145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jad.2020.05.088","article-title":"The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: results from the canadian rapid treatment center of excellence","volume":"1","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2022.12.021_bb0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jad.2022.12.021_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis","volume":"27","author":"Medeiros","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"145","key":"10.1016\/j.jad.2022.12.021_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpsychires.2021.11.036","article-title":"Pharmacogenomics of ketamine: a systematic review","volume":"1","author":"Meshkat","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.12.021_bb0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.psyneuen.2018.05.013","article-title":"Psychosocial stress and inflammation driving tryptophan break-down in children and adolescents: a cross-sectional analysis of two cohorts","volume":"94","author":"Michels","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.jad.2022.12.021_bb0170","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/npp.2013.140","article-title":"Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression","volume":"38","author":"Miller","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2022.12.021_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.10","article-title":"Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder","volume":"5","author":"Murrough","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.12.021_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/0101-60830000000027","article-title":"Biomarkers in mood disorders research: Developing new and improved therapeutics","volume":"41","author":"Niciu","year":"2014","journal-title":"Rev. Psiquiatria Cl\u00edn."},{"issue":"254","key":"10.1016\/j.jad.2022.12.021_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pscychresns.2016.06.006","article-title":"Preliminary differences in resting state MEG functional connectivity pre-and post-ketamine in major depressive disorder","volume":"30","author":"Nugent","year":"2016","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"4","key":"10.1016\/j.jad.2022.12.021_bb0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/YCO.0000000000000505","article-title":"Depression: more treatment but no drop in prevalence: how effective is treatment? And can we do better?","volume":"32","author":"Ormel","year":"2019","journal-title":"Curr. Opin. Psychiatry."},{"key":"10.1016\/j.jad.2022.12.021_bb0195","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2022.12.021_bb0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0447.2011.01706.x","article-title":"Mood effects of the amino acids tryptophan and tyrosine: \u2018Food for Thought\u2019III","volume":"124","author":"Parker","year":"2011","journal-title":"Acta Psychiatr Scandinavica."},{"key":"10.1016\/j.jad.2022.12.021_bb0205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13643-019-1252-9","article-title":"Preferred Reporting Items for Overviews of Reviews (PRIOR): a protocol for development of a reporting guideline for overviews of reviews of healthcare interventions","volume":"8","author":"Pollock","year":"2019","journal-title":"Syst. Rev."},{"issue":"276","key":"10.1016\/j.jad.2022.12.021_bb0210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jad.2020.07.083","article-title":"Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: results from the canadian rapid treatment center of excellence","volume":"1","author":"Rodrigues","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.12.021_bb0215","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder","volume":"15","author":"Rong","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2022.12.021_bb0220","first-page":"1","article-title":"The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials","volume":"13","author":"Rossi","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2022.12.021_bb0225","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jad.2011.08.001","article-title":"Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder","volume":"140","author":"Sacher","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.12.021_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","article-title":"Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine","volume":"65","author":"Salvadore","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.021_bb0235","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1017\/S1461145711001593","article-title":"An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression","volume":"15","author":"Salvadore","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2022.12.021_bb0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01066320","article-title":"Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man","volume":"15","author":"Sch\u00fcttler","year":"1987","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"Pt. B","key":"10.1016\/j.jad.2022.12.021_bb0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2022.12.021_bb0250","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"281","key":"10.1016\/j.jad.2022.12.021_bb0255","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jad.2020.11.104","article-title":"Deep learning for the prediction of treatment response in depression","volume":"15","author":"Squarcina","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.12.021_bb0260","article-title":"Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit\u2014a mechanism of relevance to resistant depression?","volume":"16","author":"Wong","year":"2016","journal-title":"PeerJ"},{"issue":"134","key":"10.1016\/j.jad.2022.12.021_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2020.12.038","article-title":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis","volume":"1","author":"Xiong","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jad.2022.12.021_bb0270","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722013817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722013817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:55:20Z","timestamp":1759031720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722013817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":54,"alternative-id":["S0165032722013817"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.021","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of ketamine's antidepressant effect: An umbrella review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}